Form EFFECT ZyVersa Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 16, 2024 |
| Accession Number: | 0001493152-24-027033 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NTC Thermistors are the Small Sensors Behind Smarter Industrial Growth
- AVIDLOVE Highlights Self-Care and Comfort-Focused Designs for International Relaxation Day
- New Crypto Coins Worth Watching, Led by a Presale That Sold Out Its First Rung
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
